Free Trial
→ Buffett’s favorite chart just hit 209% – here’s what that means for gold (From Golden Portfolio) (Ad) Buy SAVA Stock  Free SAVA Stock Alerts

Cassava Sciences (SAVA) Short Interest Ratio & Short Volume

Cassava Sciences logo
$1.61 -0.01 (-0.62%)
Closing price 04:00 PM Eastern
Extended Trading
$1.62 +0.00 (+0.31%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Cassava Sciences Short Interest Data

Cassava Sciences (SAVA) has a short interest of 11.09 million shares, representing 25.33% of the float (the number of shares available for trading by the public). This marks a -0.54% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.8, indicating that it would take 6.8 days of the average trading volume of 2.97 million shares to cover all short positions.

Current Short Interest
11,090,000 shares
Previous Short Interest
11,150,000 shares
Change Vs. Previous Month
-0.54%
Dollar Volume Sold Short
$15.86 million
Short Interest Ratio
6.8 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
48,308,000 shares
Short Percent of Float
25.33%
Today's Trading Volume
431,573 shares
Average Trading Volume
2,970,285 shares
Today's Volume Vs. Average
15%
Short Selling Cassava Sciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Cassava Sciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

SAVA Short Interest Over Time

SAVA Days to Cover Over Time

SAVA Percentage of Float Shorted Over Time

Cassava Sciences Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/202511,090,000 shares $15.86 million -0.5%25.3%6.8 $1.43
3/31/202511,150,000 shares $16.73 million -6.1%25.5%5.9 $1.50
3/15/202511,880,000 shares $33.15 million -17.8%27.1%5.2 $2.79
2/28/202514,450,000 shares $34.68 million -9.4%33.0%5.6 $2.40
2/15/202515,940,000 shares $38.57 million +0.6%36.4%3 $2.42
1/31/202515,850,000 shares $37.72 million +3.2%N/A2.9 $2.38
1/15/202515,360,000 shares $41.63 million -7.6%N/A2.8 $2.71
12/31/202416,630,000 shares $39.25 million -5.6%N/A3 $2.36
12/15/202417,620,000 shares $48.46 million +2.7%N/A3.4 $2.75
11/30/202417,160,000 shares $65.89 million -5.1%N/A3.5 $3.84
11/15/202418,080,000 shares $486.53 million -2.6%N/A4.9 $26.91
10/31/202418,570,000 shares $479.20 million -2.0%N/A10.7 $25.81
10/15/202418,940,000 shares $535.24 million +7.4%N/A7.2 $28.26
9/30/202417,630,000 shares $518.85 million +10.8%N/A5.6 $29.43
9/15/202415,910,000 shares $447.39 million +0.6%N/A4.6 $28.12
8/31/202415,810,000 shares $453.91 million -10.6%N/A4.9 $28.71
8/15/202417,680,000 shares $501.94 million -7.1%N/A5.6 $28.39
7/31/202419,030,000 shares $422.85 million +18.0%N/A6.5 $22.22
7/15/202416,130,000 shares $198.88 million +23.2%N/A8.3 $12.33
6/30/202413,090,000 shares $161.66 million +3.5%N/A9 $12.35
6/15/202412,650,000 shares $249.46 million +1.7%N/A15.7 $19.72
5/31/202412,440,000 shares $274.05 million -2.8%N/A15 $22.03
5/15/202412,800,000 shares $294.53 million -7.7%N/A15.4 $23.01
4/30/202413,870,000 shares $307.22 million +8.0%N/A17.4 $22.15
4/15/202412,840,000 shares $256.93 million +8.9%N/A17.7 $20.01
3/31/202411,790,000 shares $239.22 million -1.4%N/A17 $20.29
3/15/202411,960,000 shares $254.63 million +5.7%30.5%15.7 $21.29
2/29/202411,320,000 shares $260.13 million -3.7%28.9%11.4 $22.98
2/15/202411,760,000 shares $288.94 million -3.5%30.7%12.3 $24.57
1/31/202412,180,000 shares $291.71 million -8.6%31.8%11.5 $23.95
1/15/202413,330,000 shares $349.78 million -4.0%33.6%10.2 $26.24
12/31/202313,890,000 shares $312.66 million +8.9%35.0%9.2 $22.51
12/15/202312,760,000 shares $268.96 million -7.0%32.2%8.6 $21.08
11/30/202313,720,000 shares $285.79 million -5.8%34.7%11.2 $20.83
11/15/202314,560,000 shares $317.70 million -8.9%36.8%11.3 $21.82
10/31/202315,990,000 shares $322.20 million +14.1%40.6%12.4 $20.15
10/15/202314,020,000 shares $208.34 million -1.3%35.6%13.1 $14.86
9/30/202314,210,000 shares $236.45 million +3.7%36.1%17.2 $16.64
9/15/202313,700,000 shares $265.92 million +2.7%34.8%14.8 $19.41
8/31/202313,340,000 shares $279.74 million +8.8%33.9%14.8 $20.97
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the May 1st funding window clos
8/15/202312,260,000 shares $215.16 million +7.3%31.1%14.9 $17.55
7/31/202311,430,000 shares $251.23 million +2.1%29.0%13.4 $21.98
7/15/202311,200,000 shares $242.26 million +10.5%28.6%13.9 $21.63
6/30/202310,140,000 shares $248.63 million +8.1%25.9%13 $24.52
6/15/20239,380,000 shares $235.16 million -13.2%23.9%14.4 $25.07
5/31/202310,800,000 shares $245.27 million +6.3%27.6%15.2 $22.71
5/15/202310,160,000 shares $269.34 million -7.5%25.9%14.4 $26.51
4/30/202310,980,000 shares $254.96 million -0.6%28.0%14.5 $23.22
4/15/202311,050,000 shares $257.69 million -3.9%28.2%10.1 $23.32
3/31/202311,500,000 shares $277.38 million +9.9%30.0%9.7 $24.12
3/15/202310,460,000 shares $272.48 million -5.0%27.3%7.9 $26.05
2/28/202311,010,000 shares $271.95 million +3.9%28.7%7.9 $24.70
2/15/202310,600,000 shares $279.95 million +7.6%27.6%7.6 $26.41
1/31/20239,850,000 shares $275.80 million -4.6%25.1%6.4 $28.00
1/15/202310,320,000 shares $350.88 million +18.8%26.3%7.3 $34.00
12/30/20228,690,000 shares $256.70 million -1.3%22.1%7 $29.54
12/15/20228,800,000 shares $348.22 million -5.7%22.4%5.6 $39.57
11/30/20229,330,000 shares $324.96 million No Change23.8%4 $34.83
11/15/20229,330,000 shares $374.13 million -0.4%23.8%3.7 $40.10
10/31/20229,370,000 shares $341.44 million -2.7%24.9%2.8 $36.44
10/15/20229,630,000 shares $351.11 million -10.7%25.6%2.6 $36.46
9/30/202210,780,000 shares $450.82 million -14.1%N/A2.9 $41.82
9/15/202212,550,000 shares $396.33 million -0.2%N/A3.7 $31.58
8/31/202212,580,000 shares $323.68 million +4.4%N/A5.1 $25.73
8/15/202212,050,000 shares $243.29 million +5.4%N/A5.1 $20.19
7/31/202211,430,000 shares $186.65 million +12.3%N/A7.7 $16.33
7/15/202210,180,000 shares $243.40 million -2.2%N/A8.4 $23.91
6/30/202210,410,000 shares $292.73 million -5.1%N/A7.1 $28.12
6/15/202210,970,000 shares $294.00 million -4.9%N/A6.7 $26.80
5/31/202211,530,000 shares $352.82 million -2.7%30.9%7 $30.60
5/15/202211,850,000 shares $227.99 million +0.9%31.8%7.5 $19.24
4/30/202211,750,000 shares $245.22 million +2.5%31.5%6.9 $20.87
4/15/202211,460,000 shares $300.83 million +7.4%31.5%6.5 $26.25
3/31/202210,670,000 shares $396.28 million -2.4%29.4%6.4 $37.14
3/15/202210,930,000 shares $380.91 million -3.3%30.1%5.1 $34.85
2/28/202211,300,000 shares $480.36 million -5.4%31.1%4.7 $42.51
2/15/202211,950,000 shares $588.18 million -12.1%32.9%4.7 $49.22
1/31/202213,600,000 shares $601.80 million +4.7%37.4%4.4 $44.25
1/15/202212,990,000 shares $595.98 million -4.6%34.8%2.8 $45.88
12/31/202113,610,000 shares $594.76 million +11.7%36.5%2.8 $43.70
12/15/202112,190,000 shares $558.06 million +18.9%N/A2.2 $45.78
11/30/202110,250,000 shares $548.27 million +22.3%27.5%1.7 $53.49
11/15/20218,380,000 shares $507.07 million -26.2%22.5%1 $60.51
10/29/202111,350,000 shares $489.53 million +20.5%30.4%1.3 $43.13
10/15/20219,420,000 shares $468.08 million +7.4%25.3%1.2 $49.69
9/30/20218,770,000 shares $544.44 million -1.2%23.5%1.1 $62.08
9/15/20218,880,000 shares $390.01 million +12.4%23.8%1.1 $43.92
8/31/20217,900,000 shares $449.12 million +46.3%21.2%1.1 $56.85
8/13/20215,400,000 shares $661.88 million +35.0%14.5%1.3 $122.57
7/30/20214,000,000 shares $278.12 million -9.5%10.7%1 $69.53
The Trump Dump is starting; Get out of stocks now? (Ad)

The first 365 days of the Trump presidency… Will be the best time to get rich in American history.

If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a
7/15/20214,420,000 shares $364.34 million +11.6%11.9%1.7 $82.43
6/30/20213,960,000 shares $338.34 million +5.3%10.6%1.8 $85.44
6/15/20213,760,000 shares $271.10 million -0.5%10.1%2 $72.10
5/28/20213,780,000 shares $203.82 million +8.9%10.1%2.1 $53.92
5/14/20213,470,000 shares $131.10 million -7.7%N/A1.9 $37.78
4/30/20213,760,000 shares $178.86 million +3.6%N/A1.2 $47.57
4/15/20213,630,000 shares $129.48 million +5.5%N/A0.6 $35.67
3/31/20213,440,000 shares $151.22 million -5.8%N/A0.5 $43.96
3/15/20213,650,000 shares $195.06 million +24.2%N/A0.5 $53.44
2/26/20212,940,000 shares $149.59 million +12.2%N/A0.4 $50.88
2/12/20212,620,000 shares $126.26 million -56.2%N/A0.4 $48.19
1/29/20215,980,000 shares $111.95 million +9.5%N/A1 $18.72
1/15/20215,460,000 shares $57.22 million +2.1%N/A1.6 $10.48
12/31/20205,350,000 shares $37.50 million +2.9%N/A2 $7.01
12/15/20205,200,000 shares $40.35 million -12.9%N/A1.7 $7.76
11/30/20205,970,000 shares $46.33 million -0.3%N/A0.7 $7.76
11/15/20205,990,000 shares $50.14 million +11.8%N/A0.7 $8.37
10/30/20205,360,000 shares $46.79 million +15.5%N/A0.7 $8.73
10/15/20204,640,000 shares $50.99 million -6.8%N/A0.7 $10.99
9/30/20204,980,000 shares $57.32 million +79.1%N/A0.7 $11.51
9/15/20202,780,000 shares $19.52 million -8.0%N/A0.4 $7.02
8/31/20203,020,000 shares $9.48 million +4.5%N/A1.7 $3.14
8/14/20202,890,000 shares $9.77 million -7.1%N/A0.9 $3.38
7/31/20203,110,000 shares $9.86 million -11.1%N/A0.7 $3.17
7/15/20203,500,000 shares $12.78 million +3.2%N/A0.8 $3.65
6/30/20203,390,000 shares $10.44 million +19.4%N/A0.8 $3.08
6/15/20202,840,000 shares $7.30 million -4.4%N/A0.8 $2.57
5/29/20202,970,000 shares $6.36 million +19.8%N/A0.8 $2.14
5/15/20202,480,000 shares $5.26 million +4.2%N/A1.2 $2.12

SAVA Short Interest - Frequently Asked Questions

What is Cassava Sciences' current short interest?

Short interest is the volume of Cassava Sciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 11,090,000 shares of SAVA short. 25.33% of Cassava Sciences' shares are currently sold short. Learn More on Cassava Sciences' current short interest.

What is a good short interest ratio for Cassava Sciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SAVA shares currently have a short interest ratio of 7.0. Learn More on Cassava Sciences's short interest ratio.

Which institutional investors are shorting Cassava Sciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cassava Sciences: Jefferies Financial Group Inc., GTS Securities LLC, Wolverine Trading LLC, Squarepoint Ops LLC, Sig Brokerage LP, Prosight Management LP, Orbimed Advisors LLC, Millennium Management LLC, LMR Partners LLP, Jefferies Financial Group Inc., Group One Trading LLC, Deep Track Capital LP, Citadel Advisors LLC, Bank of America Corp DE, Jane Street Group LLC, Rosalind Advisors Inc., Diadema Partners LP, HAP Trading LLC, Concourse Financial Group Securities Inc., Affinity Asset Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Atika Capital Management LLC, Valence8 US LP, National Bank of Canada FI, JPMorgan Chase & Co., and Rosalind Advisors Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Cassava Sciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 25.33% of Cassava Sciences' floating shares are currently sold short.

Is Cassava Sciences' short interest increasing or decreasing?

Cassava Sciences saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 11,090,000 shares, a decline of 0.5% from the previous total of 11,150,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Cassava Sciences' short interest compare to its competitors?

25.33% of Cassava Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cassava Sciences: Monte Rosa Therapeutics, Inc. (16.37%), ProKidney Corp. (14.50%), Atai Life Sciences (8.91%), Phathom Pharmaceuticals, Inc. (21.93%), Atyr PHARMA INC (11.66%), Cryoport, Inc. (5.39%), Astria Therapeutics, Inc. (6.79%), Aquestive Therapeutics, Inc. (11.75%), Aura Biosciences, Inc. (4.36%), iTeos Therapeutics, Inc. (6.12%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short Cassava Sciences stock?

Short selling SAVA is an investing strategy that aims to generate trading profit from Cassava Sciences as its price is falling. SAVA shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cassava Sciences?

A short squeeze for Cassava Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SAVA, which in turn drives the price of the stock up even further.

How often is Cassava Sciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SAVA, twice per month. The most recent reporting period available is April, 15 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:SAVA) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...
Timothy Sykes | Sponsored
Elon’s Terrifying Warning Forces Trump To Take Action
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...
American Hartford Gold | Sponsored
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsored
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored